Trimovate available to prescribe again

by Chloe Harman on the 7 March 2019

GPs can prescribe the steroid/antibiotic cream Trimovate again following the product's relaunch.

Trimovate is available to prescribe again. | SHEILA TERRY/SCIENCE PHOTO LIBRARY
Trimovate is available to prescribe again. | SHEILA TERRY/SCIENCE PHOTO LIBRARY

Trimovate (clobetasone/nystatin/oxytetracycline) has been relaunched as a licensed medicine by Ennogen Healthcare and is now available at an NHS list price of £12.45 for 30g.

Further information

View Trimovate drug recordMIMS Dermatology Clinic

The product was divested by the previous manufacturer in October 2017 and its subsequent lack of availability was highlighted by GPs who took part in a recent drug shortages survey by GPonline.

Trimovate is a steroid/antibiotic combination cream used to treat steroid-responsive dermatoses where candidal or bacterial infection (except due to Acinetobacter, MRSA, Pseudomonas, Proteus, Serratia or Streptococcus B) is present or likely.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

More from MIMS

New antibiotic prescribing guidance issued for pneumonia

New antibiotic prescribing guidance issued for pneumonia

NICE has published antimicrobial prescribing guidelines...

MIMS summary of NICE COPD guidance updated

MIMS summary of NICE COPD guidance updated

Prescribers can now consult the quick-reference MIMS...

Soft-mist inhaler now available as reusable device

Soft-mist inhaler now available as reusable device

Respimat is now available as a reusable inhaler that...

NICE recommends 'innovative' treatment for type I diabetes

NICE recommends 'innovative' treatment for type I diabetes

Dapagliflozin (Forxiga) has been approved for routine...